{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:12Z","timestamp":1785766872482,"version":"3.56.0"},"reference-count":21,"publisher":"Massachusetts Medical Society","issue":"21","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"name":"CRISPR Therapeutics AG"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,11,27]]},"DOI":"10.1056\/nejmoa2511778","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:56:20Z","timestamp":1762613780000},"page":"2119-2130","source":"Crossref","is-referenced-by-count":62,"title":["Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting\n                    <i>ANGPTL3<\/i>"],"prefix":"10.1056","volume":"393","author":[{"given":"Luke J.","family":"Laffin","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland"},{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Cleveland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Victorian Heart Institute, Monash University, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell S.","family":"Scott","sequence":"additional","affiliation":[{"name":"New Zealand Clinical Research, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Clifton","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Baker","sequence":"additional","affiliation":[{"name":"Aotearoa Clinical Trials, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-2110","authenticated-orcid":false,"given":"Ashish","family":"Sarraju","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland"},{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Cleveland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Singh","sequence":"additional","affiliation":[{"name":"CRISPR Therapeutics, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Cleveland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Wolski","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Cleveland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huansheng","family":"Xu","sequence":"additional","affiliation":[{"name":"CRISPR Therapeutics, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Nielsen","sequence":"additional","affiliation":[{"name":"CRISPR Therapeutics, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimish","family":"Patel","sequence":"additional","affiliation":[{"name":"CRISPR Therapeutics, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Duran","sequence":"additional","affiliation":[{"name":"CRISPR Therapeutics, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-6464","authenticated-orcid":false,"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland"},{"name":"Cleveland Clinic Coordinating Center for Clinical Research, Cleveland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz962"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab551"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000789"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612790"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004215"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059266"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404147"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00507-0"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00004"},{"key":"e_1_3_4_11_2","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) protocol development. November 27 2017 (https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_50)."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01086-x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb44100341"},{"key":"e_1_3_4_14_2","unstructured":"Center for Biologics Evaluation and Research. Human gene therapy products incorporating human genome editing. Guidance for industry. Silver Spring MD: Food and Drug Administration January 2024 (https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing)."},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.06.026"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-023-01140-z"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.2921"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02222-w"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.4936"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013857"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00916"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02972-w"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2511778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:52:35Z","timestamp":1764791555000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2511778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":21,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,11,27]]}},"alternative-id":["10.1056\/NEJMoa2511778"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2511778","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}